Extended-Release Buprenorphine Treatments for Opioid Use Disorder – free CEU’s

Sponsor: Boston Medical Center Grayken Center for Addiction TTA, Department of Public Health, Bureau of Substance Addiction Services (DPH/BSAS)

This training is designed to provide healthcare teams with information on all the available FDA-approved monthly/weekly injectable buprenorphine formulations used to treat opioid use disorder, as well as how to incorporate them into clinical practice.

Topics include the pharmacology and side effects of injectable buprenorphine formulations, storage, administration and patient selection processes, dosage, initiation and maintenance for patients using weekly and monthly injectable doses, and the workflows and administrative tasks involved in implementing injectable buprenorphine in healthcare settings.

NOTE: This training is 60 minutes long. There will be an optional 30-minute Q&A session following the training, which will not count for credit. 

Intended audience

Physicians, advanced practice providers, nurses, social workers, recovery coaches, and all other healthcare professionals treating addiction are welcome and encouraged to attend

For more information and to register click here

Event Details